加载中
NASDAQHealthcareBiotechnology
最新数据
US$3.58
−US$1.025 · -22.26%
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
前收盘价
US$3.58
−US$1.025 · -22.26%
盘后
US$3.82
+US$0.24 · +6.70%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
日内区间
当前US$3.58
52周区间
当前US$3.58
盘中时间采用ET。市场数据可能有所延迟。
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
日内区间
当前US$3.58
52周区间
当前US$3.58
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 研究与开发 | 772.14万 USD | 352.78万 USD | 19.36万 USD | 64.64万 USD | 118.34万 USD |
| 销售、一般及管理费用 | 1792.04万 USD | 765.31万 USD | 246.48万 USD | 33.2万 USD | 25.8万 USD |
| 营业费用 | 1835.11万 USD | 1118.09万 USD | 472.99万 USD | 97.84万 USD | 144.14万 USD |
| 利息收入 | — | 10.44万 USD | 1.07万 USD | −57.54万 USD | −57.54万 USD |
| 利息支出 | 14.13万 USD | 31.75万 USD | 59.55万 USD | 52.68万 USD | 11.54万 USD |
| 折旧和摊销 | — | — | 445.95万 USD | — | — |
| 营业利润 | −1835.11万 USD | −1118.09万 USD | −472.99万 USD | −97.84万 USD | −144.14万 USD |
| 净利润 | −2536.64万 USD | −1115.55万 USD | −531.48万 USD | −169.24万 USD | −205.53万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$1.00
下跌空间 72.07%AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
